News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Quest International Announces They Will be First in US to Exhibit True 12-Bit, Grayscale, Mammographic Images


4/10/2008 1:11:55 PM

Irvine, CA – April, 2008 – Quest International, Inc. (Quest) announced they will show true 12-bit, grayscale mammographic images, utilizing an Apple Mac system, OsiriX and the Totoku, ME551i2, medical LCD display, at the upcoming Society for Imaging Informatics in Medicine (SIIM), to be held in Seattle, Washington.

Quest will be demonstrating the imaging breakthrough using the Apple Mac Pro 8-Core workstation with two ME551i2 medical, LCD displays. The ME551i2 is a 21.3-inch, 5 megapixel, DICOM-compliant diagnostic display. The ME551i2 is the only display able to interface with the new 64-bit version of OsiriX, the most advanced opensource PACS workstation DICOM viewer on the market.

The project began in early 2007 when Quest was asked about displays that could be used with Mac systems for the medical market. Immediately, Quest’s research and development team, lead by Medical Imaging Product Manager, Herb Berkwits, began researching the hardware and software requirements. “Our team learned that with some software changes, the ME551i2 would be able to display a true 12-bit image” commented Berkwits. Upon being notified by their integrators of Quest’s discovery, Apple approached the Irvine, California based company with the idea of working together to develop a software solution. Quest International’s Vice President Kaye Katouzian said, “Apple approached us with interest in the project. They were looking for display solutions, and we were happy to cooperate by supplying the ME551i2 displays they required.” “Because of our commitment to excellence in medical imaging, we were very excited to be involved with the project”, continued Katouzian.

In an effort to minimize any delays, Apple suggested that the OsiriX software development team get involved. “Quest is pleased to be working with the European OsiriX developers, providing technical assistance and support, our expertise in both software and hardware engineering inspire us to look for areas for which we can bring new technologies and benefits , said Shawn Arshadi, President of Quest International, Inc.

“As a leading provider of Medical Displays we have worked together with OEMs and distributors on many integration projects. To be selected to work with both Apple and OsiriX developers from around the world is proof of the trust industry leaders have in Quest.” said Bill Greenblatt, Vice President of Sales and Marketing at Quest International. “We are pleased to be part of the development team responsible for this breakthrough.” Greenblatt continued by saying, “As Apple and OsiriX continue to evolve and develop medical applications, Quest will be here to support developers and users.” About Totoku

Totoku is a leading manufacturer of high-end medical image displays and touch panels. Founded in 1940 and in the display business since 1968, Totoku has supplied displays for various fields and has earned high marks for its product reliability. About OsiriX OsiriX provides an open-source, intuitive and user-friendly interface tailored for physicians. The platform has been designed to support peer-to-peer technology as an alternative to conventional Picture Archive and Communication Systems (PACS) architecture. About Quest Established in 1982, Quest International, Inc., is a leading provider of diagnostic imaging displays. Offering both off the shelf and customizable display solutions, Quest is the North American Master Distributor of the entire line of Totoku Medical displays. With resolutions of 1.3MP-5MP, Quest can support all grayscale and color display requirements. In addition, Quest is also an Value-Added Reseller of NEC Medical and Large Screen displays. Headquartered in Irvine, California and in operation 26 years, Quest is ISO 9001:2000 registered. All names, product names and trademarks are property of their respective companies.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES